+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 2yec | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | HSP90 inhibitors and drugs from fragment and virtual screening | ||||||
要素 | HEAT SHOCK PROTEIN HSP 90-ALPHA | ||||||
キーワード | CHAPERONE / PU3 / ATPASE / STRESS RESPONSE / NUCLEOTIDE-BINDING / ATP-BINDING / PHOSPHOPROTEIN / PHOSPHORYLATION | ||||||
| 機能・相同性 | 機能・相同性情報sperm mitochondrial sheath / sulfonylurea receptor binding / dATP binding / CTP binding / positive regulation of protein polymerization / Scavenging by Class F Receptors / vRNP Assembly / UTP binding / chaperone-mediated autophagy / sperm plasma membrane ...sperm mitochondrial sheath / sulfonylurea receptor binding / dATP binding / CTP binding / positive regulation of protein polymerization / Scavenging by Class F Receptors / vRNP Assembly / UTP binding / chaperone-mediated autophagy / sperm plasma membrane / Respiratory syncytial virus genome replication / Rho GDP-dissociation inhibitor binding / mitochondrial transport / telomerase holoenzyme complex assembly / Uptake and function of diphtheria toxin / Drug-mediated inhibition of ERBB2 signaling / Resistance of ERBB2 KD mutants to trastuzumab / Resistance of ERBB2 KD mutants to sapitinib / Resistance of ERBB2 KD mutants to tesevatinib / Resistance of ERBB2 KD mutants to neratinib / Resistance of ERBB2 KD mutants to osimertinib / Resistance of ERBB2 KD mutants to afatinib / Resistance of ERBB2 KD mutants to AEE788 / Resistance of ERBB2 KD mutants to lapatinib / Drug resistance in ERBB2 TMD/JMD mutants / protein import into mitochondrial matrix / dendritic growth cone / TPR domain binding / PIWI-interacting RNA (piRNA) biogenesis / Assembly and release of respiratory syncytial virus (RSV) virions / non-chaperonin molecular chaperone ATPase / protein unfolding / Sema3A PAK dependent Axon repulsion / regulation of protein ubiquitination / positive regulation of cell size / HSF1-dependent transactivation / enzyme-substrate adaptor activity / response to unfolded protein / skeletal muscle contraction / regulation of protein-containing complex assembly / HSF1 activation / Attenuation phase / neurofibrillary tangle assembly / chaperone-mediated protein complex assembly / RHOBTB2 GTPase cycle / axonal growth cone / regulation of postsynaptic membrane neurotransmitter receptor levels / telomere maintenance via telomerase / positive regulation of lamellipodium assembly / nitric oxide metabolic process / response to salt stress / DNA polymerase binding / eNOS activation / positive regulation of defense response to virus by host / positive regulation of telomere maintenance via telomerase / Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation / Signaling by ERBB2 / cardiac muscle cell apoptotic process / endocytic vesicle lumen / positive regulation of cardiac muscle contraction / Loss of Nlp from mitotic centrosomes / Loss of proteins required for interphase microtubule organization from the centrosome / Recruitment of mitotic centrosome proteins and complexes / lysosomal lumen / Recruitment of NuMA to mitotic centrosomes / Anchoring of the basal body to the plasma membrane / activation of innate immune response / ESR-mediated signaling / positive regulation of interferon-beta production / HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand / protein tyrosine kinase binding / response to cold / Constitutive Signaling by Overexpressed ERBB2 / AURKA Activation by TPX2 / nitric-oxide synthase regulator activity / VEGFR2 mediated vascular permeability / response to cocaine / ATP-dependent protein folding chaperone / brush border membrane / Signaling by ERBB2 TMD/JMD mutants / Constitutive Signaling by EGFRvIII / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / DDX58/IFIH1-mediated induction of interferon-alpha/beta / cellular response to virus / Regulation of actin dynamics for phagocytic cup formation / positive regulation of protein import into nucleus / VEGFA-VEGFR2 Pathway / Regulation of necroptotic cell death / response to estrogen / histone deacetylase binding / tau protein binding / Downregulation of ERBB2 signaling / neuron migration / Chaperone Mediated Autophagy / disordered domain specific binding / positive regulation of nitric oxide biosynthetic process / Aggrephagy / MHC class II protein complex binding / The role of GTSE1 in G2/M progression after G2 checkpoint 類似検索 - 分子機能 | ||||||
| 生物種 | HOMO SAPIENS (ヒト) | ||||||
| 手法 | X線回折 / 分子置換 / 解像度: 2.1 Å | ||||||
データ登録者 | Roughley, S.D. / Hubbard, R.E. / Baker, L.M. | ||||||
引用 | ジャーナル: J.Med.Chem. / 年: 2011タイトル: How Well Can Fragments Explore Accessed Chemical Space? a Case Study from Heat Shock Protein 90. 著者: Roughley, S.D. / Hubbard, R.E. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 2yec.cif.gz | 60.4 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb2yec.ent.gz | 43.4 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 2yec.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ye/2yec ftp://data.pdbj.org/pub/pdb/validation_reports/ye/2yec | HTTPS FTP |
|---|
-関連構造データ
| 関連構造データ | ![]() 2ye2C ![]() 2ye3C ![]() 2ye4C ![]() 2ye5C ![]() 2ye6C ![]() 2ye7C ![]() 2ye8C ![]() 2ye9C ![]() 2yeaC ![]() 2yebC ![]() 2yedC ![]() 2yeeC ![]() 2yefC ![]() 2yegC ![]() 2yehC ![]() 2yeiC ![]() 2yejC ![]() 2wi1S ![]() 2cdd S: 精密化の開始モデル C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 単位格子 |
| ||||||||
| Components on special symmetry positions |
|
-
要素
| #1: タンパク質 | 分子量: 28523.869 Da / 分子数: 1 / 断片: N-TERMINAL ATP-BINDING DOMAIN, RESIDUES 9-236 / 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / 組織: MELANOMA / 器官: SKIN / 発現宿主: ![]() | ||||
|---|---|---|---|---|---|
| #2: 化合物 | | #3: 化合物 | ChemComp-XQ0 / | #4: 水 | ChemComp-HOH / | |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.55 Å3/Da / 溶媒含有率: 51.77 % / 解説: NONE |
|---|---|
| 結晶化 | pH: 6.5 / 詳細: pH 6.5 |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: 回転陽極 / タイプ: RIGAKU RUH3R / 波長: 1.5418 |
| 検出器 | タイプ: RIGAKU R-AXIS IV / 検出器: IMAGE PLATE / 日付: 2002年10月10日 / 詳細: OSMIC BLUE MIRRORS |
| 放射 | モノクロメーター: CU FILTER / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.5418 Å / 相対比: 1 |
| 反射 | 解像度: 2.1→65.94 Å / Num. obs: 16038 / % possible obs: 97 % / Observed criterion σ(I): 2 / 冗長度: 2 % / Rmerge(I) obs: 0.05 / Net I/σ(I): 7 |
| 反射 シェル | 解像度: 2.1→2.15 Å / 冗長度: 2 % / Rmerge(I) obs: 0.42 / Mean I/σ(I) obs: 2.5 / % possible all: 99.8 |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: PDB ENTRY 2WI1 解像度: 2.1→65.94 Å / Cor.coef. Fo:Fc: 0.948 / Cor.coef. Fo:Fc free: 0.923 / SU B: 6.686 / SU ML: 0.167 / 交差検証法: THROUGHOUT / ESU R: 0.218 / ESU R Free: 0.205 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 34.243 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 2.1→65.94 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
|
ムービー
コントローラー
万見について




HOMO SAPIENS (ヒト)
X線回折
引用




















































































PDBj
























